Intraoperative hypothermia is an independent risk factor for early cytomegalovirus infection in liver transplant recipients

Transplantation

Volumn 67, Issue 8, 1999, Pages 1151-1155

  Paterson, David L ^a   Stapelfeldt, Wolf H ^a   Wagener, Marilyn M ^a   Gayowski, Timothy ^a   Marino, Ignazio R ^a   Singh, Nina ^a,b  

^a VA Healthcare VISN 4   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY TEMPERATURE; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; HUMAN; HYPOTHERMIA; INFECTION RATE; INTRAOPERATIVE PERIOD; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; VIRUS REACTIVATION; WARMING;

BODY TEMPERATURE; CYTOMEGALOVIRUS INFECTIONS; HUMANS; HYPOTHERMIA, INDUCED; INTRAOPERATIVE CARE; LIVER TRANSPLANTATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0033609167     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199904270-00011     Document Type: Article

References (17)

1. Sessler DI. Mild perioperative hypothermia. N Engl J Med 1997; 336: 1730.
2. Frank SM, Higgins MS, Fleisher LA, Sitzmann JV, Raff H, Breslow MJ. Adrenergic, respiratory and cardiovascular effects of core cooling in humans. Am J Physiol 1997; 272: 557.
3. Docke WD, Prosch S, Fietze E, et al. Cytomegalovirus reactivation and tumour necrosis factor. Lancet 1994; 343: 268.
4. Mutimer D, Mirza D, Shaw J, O'Donnell K, Elias E. Enhanced cytomegalovirus viral replication associated with septic bacterial complications in liver transplant recipients. Transplantation 1997; 63: 1411.
5. Kutza AST, Muhl E, Hackstein H, Kirchner H, Bein G. High incidence of active cytomegalovirus infection among septic patients. Clin Infect Dis 1998; 26: 1076.
6. Ho M. Cytomegalovirus infection in patients with bacterial sepsis. Clin Infect Dis 1998; 26: 1083.
7. Gerna G, Revello MG, Percivalle E, et al. Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. J Clin Microbiol 1992; 30: 1232.
8. Singh N, Yu VL, Mieles L, Wagener MM, Miner RC, Gayowski T. High-dose acyclovir compared to short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients, a randomized trial. Ann Intern Med 1994; 120: 375.
9. Schmied H, Kurz A, Sessler DI, Kozek S, Reiter A. Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet 1996; 347: 289.
10. Rubin RH. Infection in the organ transplant recipient. In: Rubin RH and Young LS, eds. Clinical approach to infection in the compromised host, 3rd ed. New York: Plenum Medical Book Co., 1994: 629.
11. Adler SP. Transfusion-associated cytomegalovirus infections. Rev Infect Dis 1983; 5: 977.
12. Adler SP, Baggett J, McVoy M. Transfusion-associated cytomegalovirus infections in seropositive cardiac surgery patients. Lancet 1985; 2: 743.
13. Smith DM Jr. Immunosuppressive effects of blood transfusion. Clin Lab Med 1992; 12: 723.
14. Sayers MH, Anderson KC, Goodnough LT, et al. Reducing the risk for transfusion-transmitted cytomegalovirus infection. Ann Intern Med 1992; 116: 55.
15. Erice A, Holm MA, Gill PC, Henry S. Dirksen CL, Dunn DL, et al. Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes. J Clin Microbiol 1992; 30: 2822.
16. Hibberd PL, Tolkoff-Rubin NE, Cosimi AB, et al. Symptomatic cytomegalovirus disease in cytomegalovirus antibody seropositive renal transplant recipients treated with OKT3. Transplantation 1992; 53: 68.
17. Hibberd PL, Tolkoff-Rubin NE, Conti D et al. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in antibody-positive renal transplant recipients. Ann Intern Med 1995; 123: 39.